Front Line Genomics invites you to their event

Cancer Genomics ONLINE: Webinar 2 - Tumour Evolution, Heterogeneity and Identifying New Cancer Drivers

About this event

Cancer Genomics ONLINE

Thursday 6th, 13th and 20th July at 3pm BST / 4pm CEST / 10am EDT

Webinar 2: Tumour Evolution, Heterogeneity and Identifying New Cancer Drivers

Thursday 13th July 3pm BST / 4pm CEST / 10am EDT

Studying the evolutionary history of tumours can help uncover new cancer drivers, overcome resistance, and even forecast the evolution of disease.

This webinar will show you methods of studying tumour evolution, and how these insights may translate into clinical benefits.

Prostate Cancer Evolution and Ethnicity - David Wedge, Professor and Group Leader, Cancer Genomics and Tumour Evolution Group, University of Manchester

Insights into Lung Cancer Evolution and Metastases in TRACERx – Mariam Jamal-Hanjani, Clinical Associate Professor and Honorary Consultant, UCL

Molecular Archaeology of Cancer – Peter Van Loo, Professor and CPRIT Scholar in Cancer Research, MD Anderson Cancer Center

Upcoming webinars in this series:

Webinar 3: Genomics and a Bright Future for Precision Cancer Therapy

Sponsored by Biomodal

Thursday 20th July 3pm BST / 4pm CEST / 10am EDT

Join us for this webinar to learn how the latest breakthroughs in cancer genomics are supporting the development of novel treatment regimens and how they will advance clinical decision-making in years to come.

Personalised Treatment for Bowel Cancer Patients: The Impact of Molecular Pathology and Genomics - Nicholas West, Associate Professor of Pathology and Honorary Consultant, University of Leeds

Refining Liquid Biopsy: Generating More Information from Cell-Free DNA - Páidí Creed, Senior Director of Computational Technologies, Biomodal

Stratifying Therapy for Patients with Molecular High-Risk Myeloma - Martin Kaiser, Team Leader of the Myeloma Molecular Therapy Group, ICR

Previous webinars available on-demand:

Webinar 1: The Latest and Greatest Methods to Interrogate the Tumour Microenvironment.

The tumour microenvironment (TME) is a major source of cancer heterogeneity with a significant influence on the development, progression and treatment of cancer. Probing the TME has become an increasingly popular avenue to explore for identifying new disease pathways and therapeutic vulnerabilities.

This webinar will discuss the tools used to probe the TME for a better understanding of its influence on cancer.

Single Cell Classification of Tumour Microenvironments in Pan-Cancer Settings - Sagi Abelson, Principal Investigator, Ontario Institute for Cancer Research

Cherry-Niche : A Tool to "De-Construct" the Tumour Microenvironment and Functionally Characterise the Tumour Niche – Luigi Ombrato, Lecturer and Group Lead, Barts Cancer Institute, Queen Mary University London

Hosted by

  • Team member
    DG T
    Diana Georgi Front Line Genomics

  • Guest speaker
    DW G
    David Wedge

  • Guest speaker
    MJ G
    Mariam Jamal-Hanjani

  • Guest speaker
    PV G
    Peter Van Loo

  • Team member
    DG T
    Diana Georgi

Front Line Genomics

Delivering the Benefits of Genomics to Patients Faster

Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.